{
    "id": "8af30ca1-ed3b-4775-806f-4fcc983548c5",
    "indications": {
        "text": "osmitrol indicated : \u2022 reduction intracranial pressure treatment cerebral edema ; \u2022 reduction elevated intraocular pressure .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "instructions ( 2.1 ) : \u2022 intravenous infusion preferably large central vein . \u2022 prior , evaluate renal , cardiac pulmonary status , correct fluid electrolyte imbalances . recommended ( 2.2 ) : \u2022 , concentration rate depend age , weight condition patient , including fluid requirement , urinary output concomitant therapy . \u2022 reduction intracranial pressure : 0.25 gram/kg administered every 6 8 hours intravenous infusion 30 minutes . \u2022 reduction intraocular pressure : 1.5 2 grams/kg 15 % 20 % w/v solution single dose administered intravenously least 30 minutes .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "osmitrol injection supplied single-dose , flexible viaflex plastic containers available follows : code size ( ml ) ndc product name 2d5613 500 0338-0353-03 10 % ( 0.1 g/ml mannitol , usp ) 2d5623 500 0338-0355-03 15 % ( 0.15 g/ml mannitol , usp ) 2d5632 250 0338-0357-02 20 % ( 0.2 g/ml mannitol , usp ) 2d5633 500 0338-0357-03 20 % ( 0.2 g/ml mannitol , usp ) remove container overwrap intended . exposure pharmaceutical products heat minimized . avoid excessive heat . store room temperature ( 25\u00b0c ) ; brief exposure 40\u00b0c adversely affect product .",
    "adverseReactions": "osmitrol contraindicated patients : \u2022 known hypersensitivity mannitol [ ( 5.1 ) ] \u2022 anuria [ ( 5.2 ) ] \u2022 severe hypovolemia [ ( 5.4 ) ] \u2022 pre-existing severe pulmonary vascular congestion pulmonary edema [ ( 5.5 ) ] \u2022 active intracranial bleeding except craniotomy",
    "ingredients": [
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        }
    ],
    "organization": "Baxter Healthcare Company",
    "name": "Osmitrol",
    "effectiveTime": "20241119",
    "indications_original": "OSMITROL is indicated for: \n                  \n                  \n                     \n                        \u2022\n                        The reduction of intracranial pressure and treatment of cerebral edema;\n                     \n                     \n                        \u2022\n                        The reduction of elevated intraocular pressure.",
    "contraindications_original": "Administration Instructions ( 2.1 ): \u2022 For intravenous infusion preferably into a large central vein. \u2022 Prior to administration, evaluate renal, cardiac and pulmonary status, and correct fluid and electrolyte imbalances. Recommended Dosage ( 2.2 ) : \u2022 The dosage, concentration and rate of administration depend on the age, weight and condition of the patient, including fluid requirement, urinary output and concomitant therapy. \u2022 Reduction of Intracranial Pressure : 0.25 gram/kg administered every 6 to 8 hours as an intravenous infusion over 30 minutes. \u2022 Reduction of Intraocular Pressure : 1.5 to 2 grams/kg of a 15% or 20% w/v solution as a single dose administered intravenously over at least 30 minutes.",
    "warningsAndPrecautions_original": "OSMITROL injection is supplied in single-dose, flexible VIAFLEX plastic containers and is available as follows: \n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              Code\n                           \n                           \n                              Size (mL)\n                           \n                           \n                              NDC\n                           \n                           \n                              Product Name\n                           \n                        \n                        \n                           \n                              2D5613\n                           \n                           \n                              500\n                           \n                           \n                              0338-0353-03\n                           \n                           \n                              10% (0.1 g/mL mannitol, USP)\n                           \n                        \n                        \n                           \n                              2D5623\n                           \n                           \n                              500\n                           \n                           \n                              0338-0355-03\n                           \n                           \n                              15% (0.15 g/mL mannitol, USP)\n                           \n                        \n                        \n                           \n                              2D5632\n                           \n                           \n                              250\n                           \n                           \n                              0338-0357-02\n                           \n                           \n                              20% (0.2 g/mL mannitol, USP)\n                           \n                        \n                        \n                           \n                              2D5633\n                           \n                           \n                              500\n                           \n                           \n                              0338-0357-03\n                           \n                           \n                              20% (0.2 g/mL mannitol, USP)\n                           \n                        \n                     \n                  \n                  Do not remove container from overwrap until intended for use.\n                  Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Store at room temperature (25\u00b0C); brief exposure up to 40\u00b0C does not adversely affect the product.",
    "adverseReactions_original": "OSMITROL is contraindicated in patients with: \n                  \n                  \n                     \n                        \u2022\n                        Known hypersensitivity to mannitol [see Warnings and Precautions (5.1)]\n                     \n                     \n                        \u2022\n                        Anuria [see Warnings and Precautions (5.2)]\n                     \n                     \n                        \u2022\n                        Severe hypovolemia [see Warnings and Precautions (5.4)]\n                     \n                     \n                        \u2022\n                        Pre-existing severe pulmonary vascular congestion or pulmonary edema [see Warnings and Precautions (5.5)]\n                     \n                     \n                        \u2022\n                        Active intracranial bleeding except during craniotomy",
    "drug": [
        {
            "name": "Osmitrol",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        }
    ]
}